A July 2024 study published in JAMA Ophthalmology revealed that diabetic patients who take semaglutide have a hazard ratio of 4.28 for developing nonarteritic anterior ischemic optic neuropathy (NAION)meaning their risk is over four times greater than patients on other diabetes drugs
In follow-up study, Pan and colleagues determined that the number of pulmonary neuroendocrine cells were decreased in a mouse model of CF, resulting in diminished oxygen sensing [67]
To explore the broader impact of semaglutide on systemic pathophysiology, we performed ultra-sensitive proteomics (NULISA) on plasma samples from both groups of rats (n=12/group)
Can this medicine be taken during pregnancy
If you learn that there are very competitive products in China that are not within the scope of our display, we'd love to help you find quality resources
If you have recently begun using a GLP-1 medication, you may have encountered a familiar, uncomfortable companion: nausea